ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,674Medicare Part D Prescriptions Filled, Including Refills

Rank: 947 out of 3734

$519K Total Retail Price of All Prescriptions

Rank: 669 out of 3734

457 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 457 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 457 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

0% of this provider’s 5,954 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 472 425 1 1
HYDROCODONE-ACETAMINOPHEN 259 123 S3 2 12
AMLODIPINE BESYLATE 251 231 3 5
LISINOPRIL 236 208 4 3
LEVOTHYROXINE SODIUM 235 184 5 2
OMEPRAZOLE 219 167 6 4
WARFARIN SODIUM 175 160 7 10
DONEPEZIL HCL 155 155 8 25
ATENOLOL 155 132 8 13
METOPROLOL TARTRATE 149 144 10 6
RANITIDINE HCL 134 121 11 32
AZITHROMYCIN 131 97 12 38
METFORMIN HCL 114 102 13 8
GABAPENTIN 100 48 14 17
TRAMADOL HCL 99 83 15 20
PREDNISONE 97 83 16 42
CITALOPRAM HBR 84 58 17 16
SERTRALINE HCL 80 66 18 18
CRESTOR 78 76 19 28
OXYCONTIN 78 0 S2 19 121
ATORVASTATIN CALCIUM 76 74 21 11
LOSARTAN POTASSIUM 72 65 22 21
OXYCODONE HCL 71 0 S2 23 58
NAMENDA 70 70 24 44
FENTANYL 70 27 S2 24 65
FLUTICASONE PROPIONATE 69 58 26 46
SPIRIVA 69 67 26 40
VENTOLIN HFA 69 45 26 70
PANTOPRAZOLE SODIUM 66 66 29 22
ALENDRONATE SODIUM 65 60 30 26
CELEBREX 63 45 31 69
FUROSEMIDE 61 56 32 7
ZETIA 61 58 32 55
OXYCODONE-ACETAMINOPHEN 60 25 S2 34 51
ONDANSETRON HCL 60 0 34 262
ZOLPIDEM TARTRATE 60 49 34 24
TRAZODONE HCL 58 39 37 49
CYMBALTA 57 15 38 67
LOSARTAN-HYDROCHLOROTHIAZIDE 54 50 39 71
CLOPIDOGREL 54 51 39 23
DIPHENHYDRAMINE HCL 52 0 R 41 561
ADVAIR DISKUS 51 45 42 35
ATENOLOL-CHLORTHALIDONE 51 48 42 178
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.